BioClinica, C.R. Bard Win 2012 Microsoft Life Sciences Innovation Award
BioClinica Inc., a global provider of clinical trial management solutions, announced that it is, together with C.R. Bard, a 2012 winner of Microsoft Corporation’s prestigious Life Sciences Innovation Award. The awards, announced at the Drug Information Association’s (DIA) 48th Annual Meeting in Philadelphia, honor companies that use Microsoft solutions to realize business and information technology benefits. BioClinica was recognized for revolutionizing medicine development by helping its clients bring therapeutic breakthroughs to the market faster, fight serious ailments, improve healthcare, and enhance people's quality of life.
“Now more than ever, the life sciences industry is faced with many challenges including cutting costs and bringing new drugs and therapies to market faster,” said Andrea McGonigle, national managing director, Life Sciences, Microsoft Corporation. “We are impressed with how the winners demonstrate sustainable impacts through technology, and are proud that Microsoft’s software plays an important role in enabling these achievements in life sciences.”
BioClinica was recognized for the "Monitor Visit Report" capability of its OnPoint Clinical Trial Management System, developed for C.R. Bard, which makes it easier for clinical site monitors to enter essential study information. By synchronizing local Word documents through SharePoint, the data becomes a connected list which is then transferred and updated within OnPoint CTMS. Site monitors can complete forms anywhere, always benefiting from maximum ‘local quality’ intelligence, and synchronize the data with the web-based CTMS system whenever internet connectivity is present resulting in time savings of thousands of hours and dramatically reducing trial costs.
BioClinica and C.R. Bard were chosen for this award from a collection of life sciences corporations in the pharmaceutical, biotechnology and medical device industries that are creatively applying technology to develop therapeutic innovations. Winners were selected by a panel of industry experts.
“We are honored to have C.R. Bard and BioClinica receive this award in recognition of our partnership to bring new innovations to market. The power of being able to run a clinical trial from one's Microsoft Outlook client is extremely powerful as visit reports, open action items, clinical documents and monitoring visits are available everywhere, anytime. The moment you connect to a network everything is instantly updated, something which no other CTMS or clinical suite of products has the power to do,” said Peter Benton, President, eClinical Division of BioClinica.
BioClinica is also demonstrating Express EDC and OnPoint CTMS Metro apps on slate computers running beta versions of Windows 8 at the Drug Information Association conference, June 24 – 28, 2012 at the Pennsylvania Convention Center in Philadelphia. To see the apps in action, or to learn more about BioClinica’s eClinical solutions and Imaging Core Lab services, visit the BioClinica booth, number 2707.
Source: BioClinica Inc. via Business Wire